Mutations in KRAS genes in patients with lung cancer
allautoe 0 GECP congresses news vídeo
Mutations in KRAS genes in patients with lung cancer was also one of the topics discussed in the session “Molecular Tumor Board – when and how to diagnose and treat rarer mutations in patients with NSCLC”, of the 10th GECP Congress/ 1st Portuguese Lung Cancer Congress.
Dr.ª Daniela Madama mentions that, “with the introduction of the NGS method, it is already possible to identify the mutations present in patients” and, in this way, provide them with more therapeutic options.
Watch the expert’s video on the topic.